BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24515915)

  • 1. Rapid homogenous time-resolved fluorescence (HTRF) immunoassay for anthrax detection.
    Cohen N; Mechaly A; Mazor O; Fisher M; Zahavy E
    J Fluoresc; 2014 May; 24(3):795-801. PubMed ID: 24515915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.
    Stoddard RA; Quinn CP; Schiffer JM; Boyer AE; Goldstein J; Bagarozzi DA; Soroka SD; Dauphin LA; Hoffmaster AR
    J Immunol Methods; 2014 Jun; 408():78-88. PubMed ID: 24857756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homogeneous immunoassay for anthrax detection based on the AlphaLISA method: detection of B. anthracis spores and protective antigen (PA) in complex samples.
    Mechaly A; Cohen N; Weiss S; Zahavy E
    Anal Bioanal Chem; 2013 May; 405(12):3965-72. PubMed ID: 23388689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
    Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
    Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.
    Cote CK; Kaatz L; Reinhardt J; Bozue J; Tobery SA; Bassett AD; Sanz P; Darnell SC; Alem F; O'Brien AD; Welkos SL
    J Med Microbiol; 2012 Oct; 61(Pt 10):1380-1392. PubMed ID: 22767539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR
    Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin/ raxibacumab-treated New Zealand white rabbits.
    Corey A; Migone TS; Bolmer S; Fiscella M; Ward C; Chen C; Meister G
    Toxins (Basel); 2013 Jan; 5(1):120-38. PubMed ID: 23344456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays.
    Mabry R; Brasky K; Geiger R; Carrion R; Hubbard GB; Leppla S; Patterson JL; Georgiou G; Iverson BL
    Clin Vaccine Immunol; 2006 Jun; 13(6):671-7. PubMed ID: 16760326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against
    Majumder S; Das S; Somani VK; Makam SS; Kingston JJ; Bhatnagar R
    Front Immunol; 2019; 10():498. PubMed ID: 30941133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax.
    Gates-Hollingsworth MA; Perry MR; Chen H; Needham J; Houghton RL; Raychaudhuri S; Hubbard MA; Kozel TR
    PLoS One; 2015; 10(5):e0126304. PubMed ID: 25942409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
    Cybulski RJ; Sanz P; McDaniel D; Darnell S; Bull RL; O'Brien AD
    Vaccine; 2008 Sep; 26(38):4927-39. PubMed ID: 18657585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
    Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores.
    Kuehn A; Kovác P; Saksena R; Bannert N; Klee SR; Ranisch H; Grunow R
    Clin Vaccine Immunol; 2009 Dec; 16(12):1728-37. PubMed ID: 19793896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
    Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
    Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.